论文部分内容阅读
目的探讨婴幼儿喘息性疾病后喘息发作的预防方法。方法收集儿科住院的0～2岁的喘息性疾病患儿186例,均予常规综合治疗。对其中87例加用布地奈德悬液雾化吸入,时间为7～12d;其余99例患儿为对照组。观察1年内2组患儿喘息、咳嗽发作情况。结果治疗组患儿在1年内的喘息、咳嗽发生例数较对照组明显减少,差异有统计学意义。结论短疗程吸入布地奈德悬液可减少婴幼儿喘息性疾病后喘息、咳嗽的发作,对降低哮喘发病率有积极的临床意义。
Objective To investigate the prevention of wheezing after infants and young children wheezing diseases. Methods A total of 186 pediatric asthmatic children aged 0 ~ 2 years who were hospitalized in pediatric department were enrolled, all of whom were given conventional treatment. Among them, 87 cases were treated with budesonide suspension inhalation for 7-12 days; the other 99 cases were control group. Observe wheeze and cough in 2 groups within 1 year. Results The number of cases of wheezing and cough in treatment group was significantly less than that in control group in one year, the difference was statistically significant. Conclusions Short-course inhalation of budesonide suspension can reduce wheezing and cough after wheezing in infants and young children, and has a positive clinical significance for reducing the incidence of asthma.